MGNX vs WFC · rev $39.6M vs P/E 15, rev $22.62B
MacroGenics Inc (MGNX) versus Wells Fargo & Company (WFC) — a side-by-side from cached financials, not a winner call.
MacroGenics Inc (MGNX) is a biotechnology company listed on NASDAQ.
Wells Fargo & Company (WFC) is a banks - diversified company listed on US. It is led by Charlie Scharf.
Latest reported MGNX revenue for 2026-06-30 was $39.6M. Net income was -$17.3M. Revenue was up 90.4% from 2026-03-31 to 2026-06-30. MGNX currently screens at market cap $246.6M.
Latest reported WFC revenue for 2026-06-30 was $22.62B. Net income was $6.41B. Revenue was up 5.5% from 2026-03-31 to 2026-06-30. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
MGNX currently screens at market cap $246.6M. WFC currently screens at market cap $272.05B and trailing P/E 15.0.
Not investment advice. Open the MGNX and WFC stock pages for the full models.
Not investment advice.